Showing results (621-630 of 1,372) with videos related to

Sort By:
Pageof 138
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 27, 2026
MMSE-CDR-SB residual as an exploratory indicator of deviation from an Alzheimer's disease-typical cognitive-functional patternAmbre Mounié, Kenichiro Sato, Saki Nakashima, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 27, 2026
Decreased cerebral metabolic rate of oxygen (CMRO2) is associated with increased tau deposition in Alzheimer's diseaseHangwei Zhuang, Liangdong Zhou, Xiuyuan Hugh Wang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 3, 2026
Bridging language markers and pathology: correlations between digital speech measures and surrogate CSF biomarkers in Alzheimer's diseaseYijiang Pang, Liu Chen, Hiroko H Dodge, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 26, 2026
Cochlear implants are associated with reduced cognitive decline risk: A 20-year cohort studyFilippos Anagnostakis, Michail Kokkorakis, Ilias Papadimopoulos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 8, 2026
Arterial stiffness and risk of dementia in late life: The ARIC neurocognitive studyJenna Barbee, James Russell Pike, Jingkai Wei, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 27, 2026
Deep learning-based cortical thickness maps for diagnosis of neurodegenerative diseases: a rater studyEvamaria O Riedel, Fabian Bongratz, Benedikt Zott, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 1, 2026
Lecanemab in symptomatic PSEN1 p.Met233Val early-onset Alzheimer's disease: Neuroimaging safety, regional amyloid-PET dynamics, and longitudinal plasma biomarkersMin-Young Noh, Wonjae Sung, Hyunkee Kim, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 23, 2026
Anti-amyloid immunotherapy and brain volume trajectories in early-onset versus late-onset Alzheimer's diseaseRashi I Mehta, Methasit Jaisa-Aad, Camila Vieira Ligo Teixeira, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 15, 2026
Linking cognitive variability and Alzheimer's disease biomarkers by neurocognitive statusShayne S-H Lin, Alicia Milam, Andrew M Kiselica, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 18, 2026
Individualized cholinergic pathway degeneration in Alzheimer's disease characterized by normative modelingShuoyun Feng, Huixiang Zhuang, Chang Xu, et al.
Pageof 138